These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 28132807)

  • 1. HBXIP up-regulates ACSL1 through activating transcriptional factor Sp1 in breast cancer.
    Wang Y; Cai X; Zhang S; Cui M; Liu F; Sun B; Zhang W; Zhang X; Ye L
    Biochem Biophys Res Commun; 2017 Mar; 484(3):565-571. PubMed ID: 28132807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The oncoprotein HBXIP up-regulates FGF4 through activating transcriptional factor Sp1 to promote the migration of breast cancer cells.
    Shi H; Li Y; Feng G; Li L; Fang R; Wang Z; Qu J; Ding P; Zhang X; Ye L
    Biochem Biophys Res Commun; 2016 Feb; 471(1):89-94. PubMed ID: 26828265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The oncoprotein HBXIP upregulates PDGFB via activating transcription factor Sp1 to promote the proliferation of breast cancer cells.
    Zhang Y; Zhao Y; Li L; Shen Y; Cai X; Zhang X; Ye L
    Biochem Biophys Res Commun; 2013 May; 434(2):305-10. PubMed ID: 23537647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The oncoprotein HBXIP activates transcriptional coregulatory protein LMO4 via Sp1 to promote proliferation of breast cancer cells.
    Yue L; Li L; Liu F; Hu N; Zhang W; Bai X; Li Y; Zhang Y; Fu L; Zhang X; Ye L
    Carcinogenesis; 2013 Apr; 34(4):927-35. PubMed ID: 23291272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncogenic HBXIP enhances ZEB1 through Sp1 to accelerate breast cancer growth.
    Jiang Y; Wang D; Ren H; Shi Y; Gao Y
    Thorac Cancer; 2018 Dec; 9(12):1664-1670. PubMed ID: 30273966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The oncoprotein hepatitis B X-interacting protein promotes the migration of ovarian cancer cells through the upregulation of S-phase kinase-associated protein 2 by Sp1.
    Xu F; Zhu X; Han T; You X; Liu F; Ye L; Zhang X; Wang X; Yao Y
    Int J Oncol; 2014 Jul; 45(1):255-63. PubMed ID: 24788380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncoprotein HBXIP Modulates Abnormal Lipid Metabolism and Growth of Breast Cancer Cells by Activating the LXRs/SREBP-1c/FAS Signaling Cascade.
    Zhao Y; Li H; Zhang Y; Li L; Fang R; Li Y; Liu Q; Zhang W; Qiu L; Liu F; Zhang X; Ye L
    Cancer Res; 2016 Aug; 76(16):4696-707. PubMed ID: 26980761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The oncoprotein HBXIP enhances angiogenesis and growth of breast cancer through modulating FGF8 and VEGF.
    Liu F; You X; Wang Y; Liu Q; Liu Y; Zhang S; Chen L; Zhang X; Ye L
    Carcinogenesis; 2014 May; 35(5):1144-53. PubMed ID: 24464787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The oncoprotein HBXIP promotes human breast cancer growth through down-regulating p53 via miR-18b/MDM2 and pAKT/MDM2 pathways.
    Li H; Wang Z; Jiang M; Fang RP; Shi H; Shen Y; Cai XL; Liu Q; Ye K; Fan SJ; Zhang WY; Ye LH
    Acta Pharmacol Sin; 2018 Nov; 39(11):1787-1796. PubMed ID: 30181579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The oncoprotein HBXIP uses two pathways to up-regulate S100A4 in promotion of growth and migration of breast cancer cells.
    Liu S; Li L; Zhang Y; Zhang Y; Zhao Y; You X; Lin Z; Zhang X; Ye L
    J Biol Chem; 2012 Aug; 287(36):30228-39. PubMed ID: 22740693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The oncoprotein HBXIP modulates the feedback loop of MDM2/p53 to enhance the growth of breast cancer.
    Li H; Liu Q; Wang Z; Fang R; Shen Y; Cai X; Gao Y; Li Y; Zhang X; Ye L
    J Biol Chem; 2015 Sep; 290(37):22649-61. PubMed ID: 26229107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The oncoprotein HBXIP up-regulates YAP through activation of transcription factor c-Myb to promote growth of liver cancer.
    Wang Y; Fang R; Cui M; Zhang W; Bai X; Wang H; Liu B; Zhang X; Ye L
    Cancer Lett; 2017 Jan; 385():234-242. PubMed ID: 27765671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncoprotein HBXIP induces PKM2 via transcription factor E2F1 to promote cell proliferation in ER-positive breast cancer.
    Liu BW; Wang TJ; Li LL; Zhang L; Liu YX; Feng JY; Wu Y; Xu FF; Zhang QS; Bao MZ; Zhang WY; Ye LH
    Acta Pharmacol Sin; 2019 Apr; 40(4):530-538. PubMed ID: 29925919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The oncoprotein HBXIP promotes glucose metabolism reprogramming via downregulating SCO2 and PDHA1 in breast cancer.
    Liu F; Zhang W; You X; Liu Y; Li Y; Wang Z; Wang Y; Zhang X; Ye L
    Oncotarget; 2015 Sep; 6(29):27199-213. PubMed ID: 26309161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-205 modulates abnormal lipid metabolism of hepatoma cells via targeting acyl-CoA synthetase long-chain family member 1 (ACSL1) mRNA.
    Cui M; Wang Y; Sun B; Xiao Z; Ye L; Zhang X
    Biochem Biophys Res Commun; 2014 Feb; 444(2):270-5. PubMed ID: 24462768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The oncoprotein HBXIP up-regulates Skp2 via activating transcription factor E2F1 to promote proliferation of breast cancer cells.
    Xu F; You X; Liu F; Shen X; Yao Y; Ye L; Zhang X
    Cancer Lett; 2013 Jun; 333(1):124-32. PubMed ID: 23352642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The oncoprotein HBXIP upregulates Lin28B via activating TF II D to promote proliferation of breast cancer cells.
    Liu Q; Bai X; Li H; Zhang Y; Zhao Y; Zhang X; Ye L
    Int J Cancer; 2013 Sep; 133(6):1310-22. PubMed ID: 23494474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The oncoprotein HBXIP enhances migration of breast cancer cells through increasing filopodia formation involving MEKK2/ERK1/2/Capn4 signaling.
    Li Y; Zhang Z; Zhou X; Li L; Liu Q; Wang Z; Bai X; Zhao Y; Shi H; Zhang X; Ye L
    Cancer Lett; 2014 Dec; 355(2):288-96. PubMed ID: 25304384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HBXIP-elevated methyltransferase METTL3 promotes the progression of breast cancer via inhibiting tumor suppressor let-7g.
    Cai X; Wang X; Cao C; Gao Y; Zhang S; Yang Z; Liu Y; Zhang X; Zhang W; Ye L
    Cancer Lett; 2018 Feb; 415():11-19. PubMed ID: 29174803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The oncoprotein HBXIP suppresses gluconeogenesis through modulating PCK1 to enhance the growth of hepatoma cells.
    Shi H; Fang R; Li Y; Li L; Zhang W; Wang H; Chen F; Zhang S; Zhang X; Ye L
    Cancer Lett; 2016 Nov; 382(2):147-156. PubMed ID: 27609066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.